Evidence map›Paper›PMID 38004413›Full record

ArticlePharmaceuticals (Basel, Switzerland)2023

Cleomin Exerts Acute Antinociceptive Effects in Mice via GABA

Luíza Carolina França Opretzka, Max Denisson Maurício Viana, Alyne Almeida de Lima, Thalisson Amorim de Souza, Marcus Tullius Scotti, Josean Fechine Tavares, Marcelo Sobral da Silva, Milena Botelho Pereira Soares, Cristiane Flora Villarreal

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Pharmaceuticals (Basel, Switzerland) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Luíza Carolina França OpretzkaSchool of Pharmacy, Federal University of Bahia, Salvador 40170115, BA, Brazil.ORCID 0000-0002-7941-6855
Max Denisson Maurício VianaSchool of Pharmacy, Federal University of Bahia, Salvador 40170115, BA, Brazil.ORCID 0000-0002-1650-4460
Alyne Almeida de LimaGonçalo Moniz Institute, FIOCRUZ, Salvador 40296710, BA, Brazil.
Thalisson Amorim de SouzaInstitute for Research on Drugs and Medicines, Federal University of Paraíba, João Pessoa 58059900, PB, Brazil.ORCID 0000-0002-6000-8747
Marcus Tullius ScottiInstitute for Research on Drugs and Medicines, Federal University of Paraíba, João Pessoa 58059900, PB, Brazil.ORCID 0000-0003-4863-8057
Josean Fechine TavaresInstitute for Research on Drugs and Medicines, Federal University of Paraíba, João Pessoa 58059900, PB, Brazil.ORCID 0000-0003-0293-2605
Marcelo Sobral da SilvaInstitute for Research on Drugs and Medicines, Federal University of Paraíba, João Pessoa 58059900, PB, Brazil.ORCID 0000-0003-3451-8468
Milena Botelho Pereira SoaresGonçalo Moniz Institute, FIOCRUZ, Salvador 40296710, BA, Brazil.
Cristiane Flora VillarrealSchool of Pharmacy, Federal University of Bahia, Salvador 40170115, BA, Brazil.ORCID 0000-0002-0113-7864
Universidade Federal da Paraíba · BRUniversidade Federal da Bahia · BRFundação Oswaldo Cruz · BRServiço Nacional de Aprendizagem Industrial · BR

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior finance code 001Fundação de Amparo à Pesquisa do Estado da Bahia [PIE0009/2022National Council for Scientific and Technological Development INCT-RENNOFITO 465536/2014-0
6 · The paper itself

Abstract

Cleomin, a 1,3-oxazolidine-2-thione, was recently isolated from

Indexed as

antinociceptioncholinergic receptorcleominGABAergic receptorNeocalyptrocalix longifoliumpain

Identifiers

PMID38004413
PMCPMC10675606
OpenAlexW4388233040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.